The 6th International Conference on Biomedical Engineering (ICoBE 2023) will be hosted by the Biomedical Electronic Engineering Programme, Faculty of Electronic Engineering & Technology, Universiti Malaysia Perlis (UniMAP) from 4th to 5th September 2023 in the World Trade Centre, Kuala Lumpur, Malaysia. The theme for this year is "Be The Change: The Key to Better Healthcare Quality." ICoBE 2023 will be held as a hybrid event allowing both onsite and online participation. It will be held concurrently with 8 other international conferences, which focus on different issues pertaining to their respective theme, under the Global Trends in Engineering, Science & Technology Congress 2023 (GTEST2023).
ICoBE 2023 is a continuation of the previous conferences successfully held in 2012, 2015, 2017, 2019 and 2021. The conference aims to provide a forum for presenting and discussing cutting-edge research in biomedical engineering and healthcare technologies. It plays a vital role in providing a platform for scientists, researchers, engineers and postgraduates worldwide to share their ideas, knowledge and experience. The biennial ICoBE conference attracts professionals from various disciplines associated with biomedical engineering. Delegates and attendees can enjoy many different sessions, including oral presentations, poster sessions and workshops, that offer a comprehensive forum to explore topics relevant to biomedical engineering.
The ICoBE 2023 organizing committee has been working diligently at planning the conference. We are dedicated to ensuring that ICoBE 2023 will be an excellent experience for everyone. We look forward to receiving your paper submissions and meeting each of you in ICoBE 2023.
Accepted papers will be published in the ICoBE 2023 Proceedings in the IFMBE Proceedings (Scopus-indexed) or as journal articles in the Journal of Advanced Research in Applied Sciences and Engineering Technology (JARASET) (Scopus-indexed; with an additional fee).
Please visit our official website for more information and follow us on Facebook.
